Latest Insurance News

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.

AUCyber Limited reported a decline in Q3 FY25 cash receipts amid strategic rationalisation and a completed takeover by 5G Networks Limited, which now controls nearly 90% of shares. The company also refreshed its leadership and raised $2.75 million through an entitlement offer.

Control Bionics reports its strongest US revenue in years alongside Australia’s best quarter since 2022, propelled by new product launches and strategic investments.

Invert Graphite has lodged a prospectus to raise up to A$3.5 million through a share offer priced at A$0.03 each, while advancing its acquisition of a Tanzanian critical minerals project. The company reported no exploration activity this quarter and incurred operating losses, reflecting a transitional phase ahead of relisting.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

Emyria Limited reports sustained clinical success in its PTSD program, launches a new treatment-resistant depression therapy, and opens a second Empax Centre to meet growing demand. The company is progressing funding discussions with health insurers and government bodies to support expansion.

Vital Metals is nearing completion of a pivotal Scoping Study for its Tardiff deposit in Canada, while spearheading a new Canadian rare earths consortium and securing fresh funding to support its development ambitions.

FINEOS Corporation Holdings PLC reported a robust first quarter for FY25, with cash balances soaring to €35.4 million and customer receipts up 40% year-on-year, underpinned by successful platform deployments and a healthy sales pipeline in North America.

Aroa Biosurgery reports a second consecutive quarter of positive operating cash flow and record sales for its Myriad product line, while maintaining full-year FY25 revenue and EBITDA guidance.

Aeeris Ltd delivered solid Q3 FY2025 results, driven by strong recurring revenue growth, a successful new product launch, and strategic moves to internalise key forecasting capabilities.

29Metals Limited reports solid operational progress at Golden Grove with cost improvements and project development, while Capricorn Copper remains suspended focusing on water management and regulatory compliance. The company completes senior debt refinancing, maintaining strong liquidity and guidance.

Talius Group reported a solid March quarter with rising revenue, a strategic partnership with Lifestyle SA, and the rollout of its proprietary RTLS software, signaling strong momentum in aged care technology.